77 results
S-3ASR
EX-1.2
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
, proceeding, inquiry or investigation brought by or before any governmental entity now pending or, to the knowledge of the Company, threatened, against … administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation
S-3ASR
EX-4.3
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
or within the discretion or rights or powers conferred upon it by this Indenture;
(f) The Trustee shall not be bound to make any investigation … or liabilities likely to be incurred by it in the making of such investigation is, in the opinion of the Trustee, not reasonably assured to the Trustee
8-K
EX-10.1
IMVT
Immunovant Inc
28 Sep 23
Entry into a Material Definitive Agreement
5:23pm
in the Shares as a result of any general solicitation or general advertising. The Investor acknowledges that: (a) it has conducted its own investigation
8-K
EX-1.1
qfgte8mt47afl7hgzb
28 Sep 23
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-1.1
j8nztd o2yk
4 Oct 22
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock
5:28pm
8-K
EX-10.1
8v76tz2gf5o
15 Sep 21
Immunovant Appoints Renee Barnett as Chief Financial Officer
7:23am
8-K
EX-10.1
50mfzghk w0y0en2
2 Aug 21
Immunovant Receives $200 Million Strategic Investment from Roivant Sciences
8:09am